Comments submitted regarding Public Notification of Emerging Postmarket Medical Device Signals ("Emerging Signals"). (Docket number: FDA-2015-D-4803). Click here to read the comments and impact on ACRP Members.
Comments submitted regarding Clinical Outcome Assessment Compendium. (Docket number:FDA-2015-N-5106). Click here to read the comments and impact on ACRP Members.
Comments regarding the public consultation on the Revision of CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects.
Comments submitted to the FDA regarding Safety Assessment for IND Safety Reporting. (Docket number: FDA-2015-D-4562).
Comments submitted regarding Guideline for good clinical practice E6(R2). (Identifier:EMA/CHMP/ICH/135/1995). Click here to read the comments and impact on ACRP Members.
